1 Novozymes
Novozymes is the leading global industrial enzyme and microbial preparations company, with more than 40% of the world market share.In 2001, Novozymes was spun off from Novo Nordisk, a leading Danish pharmaceutical company; in 2004, Novozymes In 2004, Novozymes' global sales revenue reached 1 billion dollars, with operations in 130 countries. For five consecutive years, Novozymes has been ranked No. 1 in the Dow Jones Sustainability Index for corporate sustainability in the global and European pharmaceutical/biotech sectors. Novozymes has more than 4,000 active patents, patents pending and patent licenses. In its research and development efforts, Novozymes utilizes a number of advanced core technologies in traditional microbiology, modern biochemistry and molecular biology, including expression cloning, recombinant technologies, protein engineering and high-throughput screening technologies, in an effort to provide a wide range of enzymes to a broad range of customers.
2 Cardinal
Cardinal Health Group is a global top 100 company specializing in the research, production and global sales of health nutritional products, health food and healthcare. Cardinal International Group is the supplier of drugs and nutritional foods to 90% of the hospitals in the United States. Now the world's top science academies in the field of health and nutritional food, biology and world-renowned international biologists to carry out a wide range of technical cooperation, developed a world-renowned, with the international leading level of the new generation of health and nutritional products series. And using the most advanced biological gene purification technology in the world today, the activity of the extracted nutrients is preserved to the maximum extent. The series of products have been in more than 100 countries and regions around the world to establish sales outlets, mainly in the United States, the European Union countries, Canada, RB, Singapore and so on. Cardinal products won the highest international quality assessment: the world's largest manufacturer and seller of nutritional health products; global sales champion, 2004 turnover of 56.9 billion U.S. dollars; the global market share of nutritional health products up to 40%; given the AAAAA +1 the highest international credibility rating; with the world's largest nutritional products R & D center and more than 1,000 specializing in product research and development of scientists, more than half of whom have a doctorate degree. scientists, more than half of whom hold doctoral degrees.
Cardinal's health food products have been recognized by Nutritiona1 0utlook, the nation's leading nutritional food magazine, as the only nutritional food manufacturer and distributor of the year in the U.S. In 2004, Cardinal's health food products were recognized by Shuster Laboratories Inc, the nation's leading independent health food review organization, in accordance with the FDA's Good Manufacturing Practices standards. Shuster Laboratories Inc, the leading independent health food reviewer in the U.S., has been recognized by the U.S. Food and Drug Administration (FDA) as one of the top 100 companies in the world for five consecutive years (2000-2004); and the group's assets have a market value of $100 billion, which is the highest level of the U.S. publicly traded group of companies.
3 GE Healthcare (formerly Amersham)
GE Healthcare Biosciences, Inc. was formerly known as Amersham Biotechnology, Inc. Amersham is a world-leading biotechnology products company. Its mission is to provide advanced scientific technologies, instruments and reagents to researchers engaged in research and production in the life sciences to effectively accelerate the entire development process from genetics to drug production. At the same time, we provide world-class technology, instruments, reagents and the best after-sales service to users active in the life sciences and in the field of gene-to-drug research and production.
GE Healthcare's products include molecular biology reagents, electrophoresis instruments, chromatography equipment, chromatography media, membrane separation, spectrophotometers, etc., covering the entire process from upstream molecular biology to downstream biomolecule separation and purification. The company has many famous brands, such as biochemical reagents USB, electrophoresis reagents DIGE, PlusOne, electrophoresis instruments Hofer, Ettan, luminescence reagents ECL, blotting membranes Hybond, chromatography media Sephadex, Sepharose, HiTrap, etc. The company's products are widely used in the field of biochemistry, biotechnology, biotechnology and biotechnology.
GE Healthcare products enjoy a high reputation among users, and they are favored by many users for their leading technology, complete variety, excellent quality and considerate service.
4 BD
BD is one of the world's largest medical technology companies that manufactures and markets medical devices, systems and reagents, and is committed to improving the health of people around the world.BD focuses on improving drug treatments, increasing the quality and speed of diagnosis of infectious diseases, and advancing research and discovery of novel drugs and vaccines. BD has strong research and development capabilities to fight many of the world's toughest diseases. Founded in 1897 in New York City and headquartered in Franklin Lakes, New Jersey, the company employs more than 25,000 people in approximately 50 countries. The company serves medical institutions, life science research institutes, clinical laboratories, industry and the general public, and has become a multinational company with more than 10,000 products, the world's largest supplier of syringes and medical disposable products, with a market share of 45% of the world's syringes, and 80% of the European and American syringes. In 2005, the company's global sales reached 5.4 billion U.S. dollars, invested nearly 300 million U.S. dollars in research and development costs. BD in more than a hundred years of development in the process of its strong competitive advantage has acquired more than a dozen related medical equipment and medical device companies, so that the company's scale of operation, market share and overall competitiveness of the development of the leap, for the world counterparts in the spotlight.
5 Roche
Roche (Roche) was founded in 1896, headquartered in Basel, Switzerland, in the field of pharmaceuticals and diagnostics is the world's leading R & D-based, innovation-driven health business one of the companies. Roche is committed to its two core businesses - pharmaceuticals and diagnostics, providing innovative products and services from early detection, prevention, diagnosis to treatment, thus improving human health standards and quality of life. Roche is a global leader in in vitro diagnostics, antitumor drugs and transplantation drugs; and a market leader in virology and other key disease areas such as autoimmune diseases, inflammation, metabolism and central nervous system diseases. After more than 100 years of development, the Roche Group has a presence in more than 150 countries around the world,*** employs around 75,000 people, and has established business alliances in research and development with a number of partners, including Genentech (USA), which is a Roche holding company, and RB Chugai Pharmaceuticals. With a focus on sustainability, Roche maintains a strong operational performance. In 2006, the Roche Group generated sales of CHF 33.3 billion in the Pharmaceuticals Division and CHF 8.7 billion in the Diagnostics Division.
6 Wyeth
Wyeth is one of the world's top 500 companies and one of the world's largest R&D-based pharmaceutical and healthcare companies. Wyeth is a global leader in the research, development, manufacture and marketing of pharmaceuticals, vaccines, biologics, nutraceuticals and over-the-counter medicines. Wyeth's products improve the quality of life of people around the world. Wyeth's main business units are Wyeth Pharmaceuticals, Wyeth Health Pharmaceuticals and Fort Dodge Animal Health.
Wyeth has a long history of leadership in pharmaceuticals, vaccines and biotechnology. Wyeth has industry-leading products in the areas of women's health care, neurological disorders, musculoskeletal disorders, cardiovascular disease treatments, vaccines, anti-infectives, hemophilia, immunologics and antitumors. Wyeth is also a leader in the field of nutritional products and in the field of health medicines.
Wyeth has two investments in China: Wyeth Pharmaceutical Co., Ltd., a wholly owned subsidiary of Wyeth, formerly known as Suzhou Lida Pharmaceuticals, established in 1991 with a total investment of $29.9 million; and Wyeth Nutritional Products Co. Ltd. was established in 1995 with a total investment of US$24.0 million, for a combined total investment of US$53.9 million. Wyeth Pharmaceuticals (China) employs more than 1,000 people in China and Hong Kong. Wyeth Pharmaceuticals (China) Co., Ltd. was founded in 1992 in Delaware, USA, and like Wyeth Pharmaceuticals (USA), is a part of Wyeth. Its office in China was established in 1994 in Shanghai. The scope of business of the Shanghai office is to engage in business liaison for the import and export trade of nutritional and pharmaceutical products manufactured by Wyeth and its subsidiaries.
7 Bayer
Bayer Pharma is a global pharmaceutical giant with approximately 350 companies on five continents and 115,400 employees (as of December 31, 2003). It conducts its business activities primarily in Europe, North America and the Far East. The Bayer Group is headquartered in Leverkusen, Germany. The town is located on the east bank of the Rhine River, between the cities of Cologne and Düsseldorf. From its headquarters in Leverkusen, Bayer manages and coordinates its business activities worldwide. in 2003, Bayer generated sales of around 12 billion euros in the European market, accounting for more than 40 percent of the Group's total sales. An integrated distribution network and major production facilities in Germany, Belgium, France, the United Kingdom, Italy and Spain give Bayer a strong position in this important economic region. Bayer employs a total of 65,400 people (as of August 30, 2004) in its European companies. Greater China is Bayer's second largest single market in Asia, accounting for approximately one quarter of total sales in the region.
8 Novartis
Novartis AG is a leading multinational company in the global pharmaceutical and consumer healthcare industries. in 2004, the Group's total sales amounted to US$28,247 million, with a net income of US$5,767 million, and the Group's investment in research and development amounted to approximately US$4,200 million. Novartis is headquartered in Basel, Switzerland, and has operations in more than 140 countries and regions around the world, with approximately 81,400 employees. 2004 Business Week ranked Novartis as the largest Swiss company by market capitalization, ranking 21st globally, and 3rd in the world's pharmaceutical industry. 2000-2004, Novartis*** had 13 new medicines approved by the U.S. FDA, ranking No. 1 and No. 2 in the global pharmaceutical industry. Novartis ranked first in the global pharmaceutical industry, followed by the second-ranked company with only nine approved new drugs. Novartis is one of the world's most innovative pharmaceutical and healthcare companies. novartis is derived from the Latin word novae artes, meaning new technology, a metaphor for Novartis' focus on research and development to bring innovative products to human health. novartis' Chinese name, Novartis, is taken to mean Commitment to China, which means that the company is committed to improving the health and quality of life of the Chinese people with the same commitment to innovation through innovative products and services as before. Novartis' Chinese name, Novartis, means Commitment to China, which means that the company is committed to improving the health and quality of life of the Chinese people through innovative products and services. Novartis' cooperation with China can be traced back to more than 100 years ago. Currently, Novartis has a total investment of approximately US$100 million in China, employs 1,700 people, and has established four subsidiaries, namely Beijing Novartis Pharmaceuticals Co., Ltd, Shanghai Novartis Vision Contact Lens Co., Ltd, Shanghai Novartis Animal Health Co., Ltd, and Shanghai Novartis Trading Co., Ltd, whose businesses cover all of the company's business areas such as patented pharmaceuticals, generics, consumer healthcare, eye care, and animal healthcare.
9 Procter & Gamble
Founded in 1837, Procter & Gamble is one of the world's largest consumer products companies, with annual sales of $51.4 billion in fiscal 2003-2004. P&G is ranked 86th on FORTUNE magazine's latest list of the world's 500 largest industrial/service companies. P&G employs nearly 100,000 people worldwide, has factories and subsidiaries in more than 80 countries, and operates more than 300 brands of products that are sold in more than 160 countries and regions, including fabrics and home care, hair and beauty, baby and home care, health care, and food and beverages.
10 COFCO (Special Recommendation)
COFCO Corporation ("COFCO") is China's largest grain, oil and food import and export company and a strong food producer. COFCO is China's largest grain, oil and food import and export company and a strong food producer, with a strong reputation in the international grain, oil and food market, and outstanding achievements in the fields of agricultural products trade, biomass energy development, food production and processing, real estate, property, hotel operation and financial services, etc., which are closely related to the life of the general public, and has been ranked in the Fortune 500 since 1994.
With more than 50 years of experience in international trade, COFCO is the most important bridge between China's grain, oil and food market and the international market, and is the main channel for importing and exporting bulk agricultural products such as wheat, corn, rice and sugar. COFCO is actively involved in the development of biomass energy, and as a pioneer and major provider of fuel ethanol production in China, endeavors to contribute to national energy security and environmental protection. COFCO is committed to providing 1.3 billion Chinese people with nutritious, healthy and high-quality food, and is a leader in China in the wine, refined edible oil, flour, rice, beer malt, tomato products and other industries, with "Great Wall" wine, "Fulinmen" edible oil, "Jindi" edible oil, and "Jinti" edible oil. Its Great Wall wine, Fulinmen edible oil, Jindi chocolate, Huangzhonghuang Shaoxing wine, Zhongcha tea and other brands and products are very popular among consumers. COFCO is also the most important partner of The Coca-Cola Company in China, producing and selling Coca-Cola beverages.